KOD
KOD clinical trials: Kodiak Sciences Inc.
Every trial on ClinicalTrials.gov where Kodiak Sciences Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 12
- Trials linked
- 12
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
KOD on the catalyst calendar · KOD registry changes
- Primary completion Sep 2, 2026ActualPhase 3NCT06556368A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With...Kodiak Sciences Inc · Wet Age-related Macular DegenerationActive, not recruitingKODLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 31, 2028Sponsor estimatePhase 3NCT07734844A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTOKodiak Sciences Inc · Diabetic Macular Edema (DME)RecruitingKODLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2027Sponsor estimatePhase 3NCT06996080A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation...Kodiak Sciences Inc · Macular Edema Secondary to InflammationRecruitingKODLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2027Sponsor estimatePhase 3NCT06990399A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation...Kodiak Sciences Inc · Macular Edema Secondary to InflammationRecruitingKODLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 13, 2026ActualPhase 3NCT06270836A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic...Kodiak Sciences Inc · Diabetic RetinopathyCompletedKODLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 3, 2023ActualPhase 3NCT05066230A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)Kodiak Sciences Inc · Non-proliferative Diabetic RetinopathyTerminatedKODLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 11, 2023ActualPhase 3NCT04611152A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema...Kodiak Sciences Inc · Diabetic Macular EdemaTerminatedKODLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 27, 2023ActualPhase 3NCT04603937A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema...Kodiak Sciences Inc · Diabetic Macular EdemaTerminatedKODLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 17, 2021ActualPhase 2/Phase 3NCT04049266A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With...Kodiak Sciences Inc · Wet Macular DegenerationTerminatedKODLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 28, 2023ActualPhase 3NCT04964089A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With...Kodiak Sciences Inc · Wet Age-related Macular DegenerationCompletedKODLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 10, 2022ActualPhase 3NCT04592419A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to...Kodiak Sciences Inc · Macular EdemaCompletedKODLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2, 2021ActualPhase 1NCT03790852Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and...Kodiak Sciences Inc · Wet Age-related Macular DegenerationTerminatedKODLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 12 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner